发明名称 PRIMARY CARBOXAMIDES AS BTK INHIBITORS.
摘要 The invention provides carboxamide compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions, including rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, Crohn's disease, inflammatory bowel disease, ulcerative colitis, psoriatic arthritis, psoriasis, ankylosing spondylitis, interstitial cystitis, asthma, systemic lupus erythematosus, lupus nephritis, B cell chronic lymphocytic lymphoma, multiple sclerosis, chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, B-cell non-Hodgkin's lymphoma, activated B-celllike diffuse large B-cell, lymphoma, multiple myeloma, diffuse large B-celllymphoma, follicular lymphoma, hairy cell leukemia or Lymphoblastic lymphoma.
申请公布号 MX2015017973(A) 申请公布日期 2016.05.10
申请号 MX20150017973 申请日期 2014.06.26
申请人 ABBVIE INC. 发明人 NOEL S. WILSON;ANIL VASUDEVAN;KRISTINE E. FRANK;MICHAEL M. FRIEDMAN;GRIER A. WALLACE;LU WANG;GEORGE SHEPPARD;DOMINIQUE BONAFOUX;HEATHER M. DAVIS;J. MARTIN HEROLD;MICHAEL Z. HOEMANN;RAYMOND HUNTLEY;AUGUSTINE OSUMA;GAGANDEEP K. SOMAL;JENNIFER VAN CAMP;STACY A. VAN EPPS;LU WANG;ZHI WANG;XIANGDONG XU
分类号 A61K31/405;A61K31/454;A61K31/4545;C07D217/22 主分类号 A61K31/405
代理机构 代理人
主权项
地址